Zhejiang Jolly Pharmaceutical Co.,LTD

Informe acción XSEC:300181

Capitalización de mercado: CN¥10.9b

Salud financiera de hoja de balance de Zhejiang Jolly PharmaceuticalLTD

Salud financiera controles de criterios 6/6

Zhejiang Jolly PharmaceuticalLTD has a total shareholder equity of CN¥2.6B and total debt of CN¥381.6M, which brings its debt-to-equity ratio to 14.4%. Its total assets and total liabilities are CN¥3.9B and CN¥1.2B respectively. Zhejiang Jolly PharmaceuticalLTD's EBIT is CN¥592.6M making its interest coverage ratio -58.9. It has cash and short-term investments of CN¥786.3M.

Información clave

14.4%

Ratio deuda-patrimonio

CN¥381.56m

Deuda

Ratio de cobertura de intereses-58.9x
EfectivoCN¥786.31m
PatrimonioCN¥2.64b
Total pasivoCN¥1.23b
Activos totalesCN¥3.87b

Actualizaciones recientes sobre salud financiera

No hay actualizaciones

Recent updates

Análisis de la situación financiera

Pasivos a corto plazo: 300181's short term assets (CN¥2.3B) exceed its short term liabilities (CN¥1.2B).

Pasivo a largo plazo: 300181's short term assets (CN¥2.3B) exceed its long term liabilities (CN¥57.1M).


Historial y análisis de deuda-patrimonio

Nivel de deuda: 300181 has more cash than its total debt.

Reducción de la deuda: 300181's debt to equity ratio has reduced from 27.8% to 14.4% over the past 5 years.

Cobertura de la deuda: 300181's debt is well covered by operating cash flow (73%).

Cobertura de intereses: 300181 earns more interest than it pays, so coverage of interest payments is not a concern.


Hoja de balance


Descubre empresas con salud financiera